Thomas W Bouldin MD
Neuropathology
Professor Emeritus, Pathology & Laboratory Medicine, University of North Carolina at Chapel Hill School of Medicine
Join to View Full Profile
Chapel HillChapel Hill, NC 27514
Phone+1 919-942-8010
Dr. Bouldin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Thomas Bouldin is a board-certified anatomic pathologist and neuropathologist based in Chapel Hill, NC. He holds a medical degree from the University of North Carolina at Chapel Hill School of Medicine and completed his residency and fellowship training at the University of North Carolina Hospitals. He also completed a research fellowship in neuropathology at the Institute of Neurology, Queen Square, London. Dr. Bouldin has been an attending physician and professor at the University of North Carolina at Chapel Hill. His recent publications include research on intrathecal gene therapy for giant axonal neuropathy, intermediate filament dysregulation and astrocytopathy in the human disease model of GAN, and MYB/MYBL1-altered pediatric-type diffuse low-grade glioma.
Education & Training
University of North Carolina HospitalsFellowship, Neuropathology, 1977 - 1982
Research Fellow, Medical Research Council's Research Group in Applied Neurobiology, Institute of Neurology, Queen Square, LondonNeuropathology, 1976 - 1977- University of North Carolina HospitalsResidency, Pathology-Anatomic and Clinical, 1974 - 1976
University of North Carolina at Chapel Hill School of MedicineClass of 1974
Certifications & Licensure
NC State Medical License 1979 - 2026
American Board of Pathology Anatomic Pathology- American Board of Pathology Neuropathology
Publications & Presentations
PubMed
- Gigaxonin, mutated in Giant Axonal Neuropathy, interacts with TDP-43 and other RNA binding proteins.Cassandra L Phillips, Maryam Faridounnia, Rachel A Battaglia, Baggio A Evangelista, Todd J Cohen
Biorxiv. 2024-09-05 - 4 citationsComprehensive analysis of MYB/MYBL1-altered pediatric-type diffuse low-grade glioma.Daniel C Moreira, Ibrahim Qaddoumi, Susan Spiller, Thomas W Bouldin, Alan Davidson
Neuro-Oncology. 2024-07-05 - 1 citationsANCA-associated vasculitis presenting with isolated neurological manifestations in a patient with cocaine abuse: a case report and literature review.Fazila Aseem, Victor Lin, Abigail L Gilbert, Alfredo C Rivadeneira, J Charles Jennette
Clinical Rheumatology. 2024-04-01
Grant Support
- Influence Of Blood-Nerve Barrier Alterations On Toxic NeuropathiesNational Institute Of Environmental Health Sciences1995–1996
- Core--Models Evaluation And MaintenanceNational Institute Of Environmental Health Sciences1995–1996
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
